• Aragen Bioscience, UTS Enter MoU contractpharma
    March 11, 2020
    Aragen Bioscience, a fully owned subsidiary of GVK BIO and a large molecule CRO, and University of Technology Sydney (UTS), a university in Australia, have formed a collaboration to accelerate biologics R&D in Australia.
PharmaSources Customer Service